Intravitreal bevacizumab following laser therapy for severe retinopathy of prematurity.

Journal of pediatric ophthalmology and strabismus

Volumn 47 Online, Issue , 2010, Pages

  Erol, Nazmiye ^a   Gürsoy, Hüseyin ^b   Sahin, Afsun ^b   Basmak, Hikmet ^b  

^a OSMANGAZI UNIVERSITY MEDICAL FACULTY   (Turkey)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENESIS INHIBITOR; BEVACIZUMAB; MONOCLONAL ANTIBODY; VASCULOTROPIN A; VEGFA PROTEIN, HUMAN;

ARTICLE; CASE REPORT; DIODE LASER; DRUG ANTAGONISM; FEMALE; GESTATIONAL AGE; HUMAN; INTRAVITREAL DRUG ADMINISTRATION; LASER COAGULATION; MALE; MULTIMODALITY CANCER THERAPY; NEWBORN; RETROLENTAL FIBROPLASIA; VERY LOW BIRTH WEIGHT;

ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL, HUMANIZED; COMBINED MODALITY THERAPY; FEMALE; GESTATIONAL AGE; HUMANS; INFANT, NEWBORN; INFANT, VERY LOW BIRTH WEIGHT; INTRAVITREAL INJECTIONS; LASER COAGULATION; LASERS, SEMICONDUCTOR; MALE; RETINOPATHY OF PREMATURITY; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

MLCS; MLOWN;

EID: 84863722230     PISSN: None     EISSN: 19382405     Source Type: Journal    
DOI: 10.3928/01913913-20100818-09     Document Type: Article

References (0)